iScience,
Journal Year:
2024,
Volume and Issue:
27(6), P. 110032 - 110032
Published: May 20, 2024
Evaluation
of
the
binding
affinities
drugs
to
proteins
is
a
crucial
process
for
identifying
drug
pharmacological
actions,
but
it
requires
three
dimensional
structures
proteins.
Herein,
we
propose
novel
computational
methods
predict
therapeutic
indications
and
side
effects
candidate
compounds
from
human
protein
on
proteome-wide
scale.
Large-scale
docking
simulations
were
performed
7,582
with
19,135
revealed
by
AlphaFold
(including
experimentally
unresolved
proteins),
machine
learning
models
affinity
score
(PBAS)
profiles
constructed.
We
demonstrated
usefulness
method
predicting
559
diseases
285
toxicities.
The
enabled
which
related
had
not
been
determined
successfully
extract
eliciting
effects.
proposed
will
be
useful
in
various
applications
discovery.
Molecular Systems Biology,
Journal Year:
2024,
Volume and Issue:
20(3), P. 162 - 169
Published: Jan. 30, 2024
Abstract
Proteins
are
the
key
molecular
machines
that
orchestrate
all
biological
processes
of
cell.
Most
proteins
fold
into
three-dimensional
shapes
critical
for
their
function.
Studying
3D
shape
can
inform
us
mechanisms
underlie
in
living
cells
and
have
practical
applications
study
disease
mutations
or
discovery
novel
drug
treatments.
Here,
we
review
progress
made
sequence-based
prediction
protein
structures
with
a
focus
on
go
beyond
single
monomer
structures.
This
includes
application
deep
learning
methods
complexes,
different
conformations,
evolution
these
to
design.
These
developments
create
new
opportunities
research
will
impact
across
many
areas
biomedical
research.
Natural Product Reports,
Journal Year:
2024,
Volume and Issue:
41(10), P. 1543 - 1578
Published: Jan. 1, 2024
This
review
highlights
methods
for
studying
structure
activity
relationships
of
natural
products
and
proposes
that
these
are
complementary
could
be
used
to
build
an
iterative
computational-experimental
workflow.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 1358 - 1358
Published: Jan. 22, 2024
HDAC11
is
a
class
IV
histone
deacylase
with
no
crystal
structure
reported
so
far.
The
catalytic
domain
of
shares
low
sequence
identity
other
HDAC
isoforms,
which
makes
conventional
homology
modeling
less
reliable.
AlphaFold
machine
learning
approach
that
can
predict
the
3D
proteins
high
accuracy
even
in
absence
similar
structures.
However,
fact
models
are
predicted
small
molecules
and
ions/cofactors
complicates
their
utilization
for
drug
design.
Previously,
we
optimized
an
model
by
adding
zinc
ion
minimization
presence
inhibitors.
In
current
study,
implement
comparative
structure-based
virtual
screening
utilizing
previously
to
identify
novel
selective
stepwise
was
successful
identifying
hit
subsequently
tested
using
vitro
enzymatic
assay.
compound
showed
IC50
value
3.5
µM
could
selectively
inhibit
over
subtypes
at
10
concentration.
addition,
carried
out
molecular
dynamics
simulations
further
confirm
binding
hypothesis
obtained
docking
study.
These
results
reinforce
presented
optimization
applicability
search
inhibitors
discovery.
Journal of Cheminformatics,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: March 14, 2024
Protein-ligand
binding
site
prediction
is
a
useful
tool
for
understanding
the
functional
behaviour
and
potential
drug-target
interactions
of
novel
protein
interest.
However,
most
methods
are
tested
by
providing
crystallised
ligand-bound
(holo)
structures
as
input.
This
testing
regime
insufficient
to
understand
performance
on
targets
where
experimental
not
available.
An
alternative
option
provide
computationally
predicted
structures,
but
this
commonly
tested.
due
training
data
used,
computationally-predicted
tend
be
extremely
accurate,
often
biased
toward
holo
conformation.
In
study
we
describe
benchmark
IF-SitePred,
protein-ligand
method
which
based
labelling
ESM-IF1
language
model
embeddings
combined
with
point
cloud
annotation
clustering.
We
show
that
only
IF-SitePred
competitive
state-of-the-art
when
predicting
sites
it
performs
better
proxies
proteins
low
accuracy
has
been
simulated
molecular
dynamics.
Finally,
outperforms
other
if
ensembles
generated.
Journal of Chemical Information and Modeling,
Journal Year:
2024,
Volume and Issue:
64(5), P. 1473 - 1480
Published: Feb. 19, 2024
Predicting
whether
two
proteins
physically
interact
is
one
of
the
holy
grails
computational
biology,
galvanized
by
rapid
advancements
in
deep
learning.
AlphaFold2,
although
not
developed
with
this
goal,
promising
respect.
Here,
I
test
prediction
capability
AlphaFold2
on
a
very
challenging
data
set,
where
are
structurally
compatible,
even
when
they
do
interact.
achieves
high
discrimination
between
interacting
and
non-interacting
proteins,
cases
misclassifications
can
either
be
rescued
revisiting
input
sequences
or
suggest
false
positives
negatives
set.
thus
impaired
compatibility
protein
structures
has
potential
to
applied
large
scale.
Chemical Science,
Journal Year:
2024,
Volume and Issue:
15(21), P. 7926 - 7942
Published: Jan. 1, 2024
DiffBindFR,
a
diffusion
model
based
flexible
full-atom
protein–ligand
docking
tool,
demonstrates
its
superior
and
side-chain
refinement
accuracy
with
reliable
physical
plausibility.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(18), P. 10139 - 10139
Published: Sept. 21, 2024
Protein
three-dimensional
(3D)
structure
prediction
is
one
of
the
most
challenging
issues
in
field
computational
biochemistry,
which
has
overwhelmed
scientists
for
almost
half
a
century.
A
significant
breakthrough
structural
biology
been
established
by
developing
artificial
intelligence
(AI)
system
AlphaFold2
(AF2).
The
AF2
provides
state-of-the-art
protein
structures
from
nearly
all
known
sequences
with
high
accuracy.
This
study
examined
reliability
models
compared
to
experimental
drug
discovery,
focusing
on
common
drug-targeted
classes
as
G
protein-coupled
receptors
(GPCRs)
class
A.
total
32
representative
targets
were
selected,
including
X-ray
crystallographic
and
Cryo-EM
their
corresponding
models.
quality
was
assessed
using
different
validation
tools,
pLDDT
score,
RMSD
value,
MolProbity
percentage
Ramachandran
favored,
QMEAN
Z-score,
QMEANDisCo
Global.
molecular
docking
performed
Genetic
Optimization
Ligand
Docking
(GOLD)
software.
models’
virtual
screening
determined
ability
predict
ligand
binding
poses
closest
native
pose
assessing
Root
Mean
Square
Deviation
(RMSD)
metric
scoring
function.
function
evaluated
enrichment
factor
(EF).
Furthermore,
capability
identify
hits
key
protein–ligand
interactions
analyzed.
posing
power
results
showed
that
successfully
predicted
(RMSD
<
2
Å).
However,
they
exhibited
lower
power,
average
EF
values
2.24,
2.42,
1.82
X-ray,
Cryo-EM,
structures,
respectively.
Moreover,
our
revealed
can
competitive
inhibitors.
In
conclusion,
this
found
provided
comparable
particularly
certain
GPCR
targets,
could
potentially
significantly
impact
discovery.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(2), P. 260 - 260
Published: Jan. 10, 2025
Drug
development
faces
significant
financial
and
time
challenges,
highlighting
the
need
for
more
efficient
strategies.
This
study
evaluated
druggability
of
entire
human
proteome
using
Fpocket.
We
identified
15,043
druggable
pockets
in
20,255
predicted
protein
structures,
significantly
expanding
estimated
from
3000
to
over
11,000
proteins.
Notably,
many
were
found
less
studied
proteins,
suggesting
untapped
therapeutic
opportunities.
The
results
a
pairwise
pocket
similarity
analysis
220,312
similar
pairs,
with
3241
pairs
across
different
families,
indicating
shared
drug-binding
potential.
In
addition,
62,077
matches
between
1872
known
drug
pockets,
candidates
repositioning.
repositioned
progesterone
ADGRD1
pemphigus
breast
cancer,
as
well
estradiol
ANO2
shingles
medulloblastoma,
which
validated
via
molecular
docking.
Off-target
effects
analyzed
assess
safety
drugs
such
axitinib,
linking
newly
targets
side
effects.
For
127
new
identified,
46
out
48
documented
linked
these
targets.
These
findings
demonstrate
utility
repositioning,
target
expansion,
improved
evaluation,
offering
avenues
discovery
indications
existing
drugs.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 21, 2023
AlphaFold2
(AF2)
and
RosettaFold
have
greatly
expanded
the
number
of
structures
available
for
structure-based
ligand
discovery,
even
though
retrospective
studies
cast
doubt
on
their
direct
usefulness
that
goal.
Here,
we
tested
unrefined
AF2
models
prospectively,
comparing
experimental
hit-rates
affinities
from
large
library
docking
against
vs
same
screens
targeting
receptors.
In
σ2
5-HT2A
receptors,
struggled
to
recapitulate
ligands
had
previously
found
receptors'
structures,
consistent
with
published
results.
Prospective
models,
however,
yielded
similar
hit
rates
both
receptors
versus
experimentally-derived
structures;
hundreds
molecules
were
prioritized
each
model
structure
receptor.
The
success
was
achieved
despite
differences
in
orthosteric
pocket
residue
conformations
targets
structures.
Intriguingly,
receptor
most
potent,
subtype-selective
agonists
discovered
via
model,
not
structure.
To
understand
this
a
molecular
perspective,
cryoEM
determined
one
more
potent
selective
emerge
Our
findings
suggest
may
sample
are
relevant
much
extending
domain
applicability
discovery.